Publications: Dr Paul Pfeffer

( 2025 ) . Effects of obesity on response to asthma biologic treatment: Longitudinal data from the United Kingdom Severe Asthma Registry . The Journal of Allergy and Clinical Immunology: In Practice

( 2025 ) . Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data . The Journal of Allergy and Clinical Immunology: In Practice vol. 13 , ( 8 ) 2033 - 2048 .

( 2025 ) . Prediction Pathway for Severe Asthma Exacerbations . CHEST vol. 168 , ( 2 ) 301 - 316 .

( 2025 ) . Real-world effectiveness of biologic therapies in severe asthma patients ineligible for Phase 3 biologics Randomised Controlled Trials (RCTs): an analysis from the UK Severe Asthma Registry . ERJ Open Research00565 - 2025 .

( 2025 ) . Optimising long-term management in acute asthma presentations to the emergency department: an interview study on patient beliefs . BMJ Open Respiratory Research vol. 12 , ( 1 ) e002962 - e002962 .

( 2025 ) . Association of Frequent Short-Acting Beta-Agonist Inhaler Prescriptions with Acute Cardiovascular Events . Pragmatic and Observational Research vol. Volume 16 , 147 - 154 .

( 2025 ) . Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR) . World Allergy Organization Journal vol. 18 , ( 7 ) Article 101066 , 101066 - 101066 .

( 2025 ) . Exploring the Long-Term Utility of Remotely Monitored FeNO Suppression Testing in Severe Asthma . The Journal of Allergy and Clinical Immunology: In Practice vol. 13 , ( 7 ) 1816 - 1823 .

( 2025 ) . Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics . American Journal of Respiratory and Critical Care Medicine vol. 211 , ( 7 ) 1165 - 1174 .

( 2025 ) . Pre-biologic assessment of adherence in severe asthma and association with biologic continuation: a UK Severe Asthma Registry Study . BMJ Open Respiratory Research vol. 12 , ( 1 ) e003019 - e003019 .

( 2025 ) . Bidirectional relationship between sleep problems and long COVID: a longitudinal analysis of data from the COVIDENCE UK study . BMJ Open Respiratory Research vol. 12 , ( 1 ) e002506 - e002506 .

( 2025 ) . COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study . BMJ Open Respiratory Research vol. 12 , ( 1 ) e003158 - e003158 .

( 2025 ) . Impact of Biologic Initiation on New-onset of Corticosteroid-related Adverse Effects in Patients With Severe Asthma . American Journal of Respiratory and Critical Care Medicine vol. 211 , ( Abstracts ) A5552 - A5552 .

( 2025 ) . Are acute asthma presentations to the emergency department an opportunity for optimising long-term management? A qualitative study on beliefs and behaviours of healthcare professionals . Emergency Medicine Journal vol. 42 , ( 9 ) 608 - 614 .

( 2025 ) . Age-associated inflammatory monocytes are increased in menopausal females and reversed by Hormone Replacement Therapy .

( 2025 ) . Depemokimab efficacy/safety in patients with asthma on medium/high-dose ICS: The Phase IIIA randomised SWIFT-1/2 studies . Revue Française d'Allergologie vol. 65 , Article 104316 , 104316 - 104316 .

( 2025 ) . International Severe Asthma Registry (ISAR): 2017–2024 Status and Progress Update . Tuberculosis and Respiratory Diseases vol. 88 , ( 2 ) 193 - 215 .

( 2025 ) . Singing for lung health following completion of pulmonary rehabilitation - feasibility of a randomised controlled trial .

( 2025 ) . Experiences of user-centred design with agile development for clinically supported self-management of Long Covid . ACM Transactions on Computer-Human Interaction Article 3711839 ,

( 2025 ) . The impact of air pollution on asthma .

( 2024 ) . Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype . New England Journal of Medicine vol. 391 , ( 24 ) 2337 - 2349 .

( 2024 ) . Using normalisation process theory to evaluate the implementation of a digital health intervention in community and secondary care long COVID clinics . BMJ Open vol. 14 , ( 11 ) e092824 - e092824 .

( 2024 ) . Trajectories of functional limitations, health-related quality of life and societal costs in individuals with long COVID: a population-based longitudinal cohort study . BMJ Open vol. 14 , ( 11 ) e088538 - e088538 .

( 2024 ) . M16 Real-world outcomes from use of Enerzair inhalers with Propeller monitor connected inhaler system in a regional severe asthma adherence clinic . ‘Through the Looking Glass’ – Airway disease therapies in the real world . Conference: British Thoracic Society Winter Meeting 2024, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 27 to 29 November 2024, Programme and AbstractsA278.2 - A279 .

( 2024 ) . M20 Effectiveness of tezepelumab in patients with difficult-to-treat severe asthma: early insights from the tezepelumab patient access programme . ‘Through the Looking Glass’ – Airway disease therapies in the real world . Conference: British Thoracic Society Winter Meeting 2024, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 27 to 29 November 2024, Programme and AbstractsA281.2 - A282 .

( 2024 ) . P20 Effectiveness of benralizumab in patients with severe asthma previously treated with mepolizumab in the United Kingdom; a BPAP study post-hoc analysis . ‘George’s Marvellous Medicine’ – Biologics, biologics, biologics . Conference: British Thoracic Society Winter Meeting 2024, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 27 to 29 November 2024, Programme and AbstractsA119.2 - A120 .

( 2024 ) . P27 Real world immunogenicity of benralizumab in asthma using a specific GloBody immunoassay . ‘George’s Marvellous Medicine’ – Biologics, biologics, biologics . Conference: British Thoracic Society Winter Meeting 2024, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 27 to 29 November 2024, Programme and AbstractsA123.3 - A124 .

( 2024 ) . S118 Young-adults (16–25) with severe asthma have worse outcomes when compared to other age-groups in the UK Severe asthma registry . ‘Brave New World’ – Asthma in the new era . Conference: British Thoracic Society Winter Meeting 2024, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 27 to 29 November 2024, Programme and AbstractsA82.2 - A83 .

( 2024 ) . S33 Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials (RCTs) . ‘Harry Potter and the Sorcerer’s Biologic’ – Asthma biologics (1) . Conference: British Thoracic Society Winter Meeting 2024, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 27 to 29 November 2024, Programme and AbstractsA29.2 - A30 .

( 2024 ) . Late Breaking Abstract - Depemokimab efficacy/safety in patients with asthma on medium/high-dose ICS: The Phase IIIA randomised SWIFT-1/2 studies . Airway pharmacology and treatment . Conference: ERS Congress 2024 abstractsRCT3718 - RCT3718 .

( 2024 ) . Clinical and Economic Burden of Severe Asthma With Low Blood Eosinophil Counts . The Journal of Allergy and Clinical Immunology: In Practice vol. 12 , ( 10 ) 2785 - 2797 .

( 2024 ) . Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry . Journal of Asthma and Allergy vol. Volume 17 , 1055 - 1069 .

( 2024 ) . Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults . American Journal of Respiratory and Critical Care Medicine vol. 210 , ( 7 ) 869 - 880 .

( 2024 ) . Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK . The Lancet Psychiatry vol. 11 , ( 9 ) 696 - 708 .

( 2024 ) . Exploring Definitions and Predictors of Response to Biologics for Severe Asthma . The Journal of Allergy and Clinical Immunology: In Practice vol. 12 , ( 9 ) 2347 - 2361 .

( 2024 ) . 1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study . ERJ Open Research vol. 10 , ( 5 ) 00474 - 2024 .

( 2024 ) . Impact of comorbidities on EQ-5D quality-of-life index in severe asthma . Journal of Allergy and Clinical Immunology: Global vol. 3 , ( 3 ) Article 100286 , 100286 - 100286 .

. Understanding the Relationship Between Short-term Air Pollution Exposure and Asthma Exacerbations: East London Cohort Study . World Congress on New Technologies . Conference: The 10th World Congress on New Technologies from: 25/08/2024 to: 27/08/2024 ,

( 2024 ) . Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two‐Year Real‐World Data With Benralizumab . Clinical & Experimental Allergy vol. 54 , ( 10 ) 734 - 746 .

( 2024 ) . Immunogenicity of biologics used in the treatment of asthma . Human Antibodies vol. 32 , ( 3 ) 121 - 128 .

( 2024 ) . International Variation in Severe Exacerbation Rates in Patients With Severe Asthma . CHEST vol. 166 , ( 1 ) 28 - 38 .

( 2024 ) . COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study .

( 2024 ) . Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort . Allergy vol. 79 , ( 10 ) 2700 - 2716 .

( 2024 ) . Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma . Annals of Allergy, Asthma & Immunology vol. 132 , ( 5 ) 610 - 622.e7 .

( 2024 ) . Development and Validation of an Individualised Risk Prediction Model for Exacerbations in Patients With Severe Asthma in Real-world Settings . C102. CLINICAL AND TRANSLATIONAL ADVANCES IN ASTHMA . Conference: American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CAA6700 - A6700 .

( 2024 ) . International Variation in Exacerbation Rates in Patients With Severe Asthma . D22. ADVANCES IN HEALTH SERVICES RESEARCH IN ASTHMA . Conference: American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CAA7021 - A7021 .

( 2024 ) . Unveiling the Real-World Causal Interaction of Essential Risk Factors in Severe Asthma Exacerbation: A Bayesian Network Analysis . C94. ASTHMA QUALITY IMPROVEMENT, HEALTH SERVICES RESEARCH, AND DISPARITIES . Conference: American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CAA6605 - A6605 .

( 2024 ) . Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma . Frontiers in Immunology vol. 15 , Article 1361891 ,

( 2024 ) . Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study – PHOSP-COVID . ERJ Open Research vol. 10 , ( 4 ) 00982 - 2023 .

( 2024 ) . Bidirectional relationship between sleep problems and long COVID: a longitudinal analysis of data from the COVIDENCE UK study .

( 2024 ) . Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma . American Journal of Respiratory and Critical Care Medicine vol. 209 , ( 3 ) 262 - 272 .

( 2024 ) . Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry” . The Journal of Allergy and Clinical Immunology: In Practice vol. 12 , ( 2 ) 536 - 539 .

( 2024 ) . Accelerated immune ageing is associated with COVID-19 disease severity . Immunity & Ageing vol. 21 , ( 1 ) Article 6 ,

( 2024 ) . Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry . Annals of Allergy, Asthma & Immunology vol. 132 , ( 1 ) 42 - 53 .

( 2023 ) . Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study . International Journal of Epidemiology vol. 53 , ( 1 ) Article dyad165 ,

( 2023 ) . Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care . Thorax vol. 79 , ( 5 ) 403 - 411 .

( 2023 ) . An examination of factorial invariance of the Asthma Control Questionnaire among adults with severe asthma . PLOS ONE vol. 18 , ( 12 ) e0295493 - e0295493 .

( 2023 ) . Ethnic variation in asthma phenotypic presentation and outcomes: a cross-sectional analysis of the UK Biobank . Thorax vol. 79 , ( 2 ) 186 - 190 .

( 2023 ) . Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial . The Lancet Diabetes & Endocrinology vol. 11 , ( 12 ) 905 - 914 .

( 2023 ) . One year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study .

( 2023 ) . M25 Reductions in healthcare resource utilisation (HCRU) over 2 years of benralizumab treatment in patients with severe eosinophilic asthma; analysis from the BPAP study . ‘Against all odds’ – Fight for the future of asthma . Conference: British Thoracic Society Winter Meeting 2023, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 22 to 24 November 2023, Programme and AbstractsA275 - A275 .

( 2023 ) . P130 Clinical effectiveness over 2 years of benralizumab treatment in patients with severe eosinophilic asthma and concomitant nasal polyposis; analysis from the BPAP study . ‘The way you make me feel’ – Beyond the basics in asthma . Conference: British Thoracic Society Winter Meeting 2023, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 22 to 24 November 2023, Programme and AbstractsA185.1 - A185 .

( 2023 ) . S18 Long-term symptom profiles after COVID-19 vs other acute respiratory infections: a population-based observational study . ‘Shake it off’ – Recovery from COVID-19 . Conference: British Thoracic Society Winter Meeting 2023, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 22 to 24 November 2023, Programme and AbstractsA17 - A18 .

( 2023 ) . Long COVID research: an update from the PHOSP-COVID Scientific Summit . The Lancet Respiratory Medicine vol. 11 , ( 11 ) e93 - e94 .

( 2023 ) . Long-term symptom profiles after COVID-19 vs other acute respiratory infections: an analysis of data from the COVIDENCE UK study . eClinicalMedicine vol. 65 , Article 102251 , 102251 - 102251 .

( 2023 ) . Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study . The Lancet Respiratory Medicine vol. 11 , ( 11 ) 1003 - 1019 .

( 2023 ) . Switching patients to maintenance and reliever therapy in the Emergency Department? - A qualitative study exploring the attitudes and beliefs of patients and healthcare professionals . Airway pharmacology and treatment . Conference: ERS International Congress 2023 abstractsPA5284 - PA5284 .

( 2023 ) . Bringing the treatable traits approach to primary care asthma management . Frontiers in Allergy vol. 4 , Article 1240375 ,

( 2023 ) . Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry . The Journal of Allergy and Clinical Immunology: In Practice vol. 11 , ( 9 ) 2732 - 2747 .

( 2023 ) . Experiences of Diagnosis, Symptoms, and Use of Reliever Inhalers in Patients With Asthma and Concurrent Inducible Laryngeal Obstruction or Breathing Pattern Disorder: Qualitative Analysis of a UK Asthma Online Community . Journal of Medical Internet Research vol. 25 , e44453 - e44453 .

( 2023 ) . Understanding interventions delivered in the emergency department targeting improved asthma outcomes beyond the emergency department: an integrative review . BMJ Open vol. 13 , ( 8 ) e069208 - e069208 .

( 2023 ) . Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study . The Lancet Respiratory Medicine vol. 11 , ( 8 ) 673 - 684 .

( 2023 ) . Long-term symptom profiles after COVID-19<i>vs</i>other acute respiratory infections: a population-based observational study (COVIDENCE UK) .

( 2023 ) . Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study . BMJ Open vol. 13 , ( 6 ) e069217 - e069217 .

( 2023 ) . Identification of autoantigens and their potential post-translational modification in EGPA and severe eosinophilic asthma . Frontiers in Immunology vol. 14 , Article 1164941 ,

( 2023 ) . Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls . The Lancet Regional Health - Europe vol. 29 , Article 100635 , 100635 - 100635 .

( 2023 ) . Integration of respiratory physiology and clinical reasoning in the early years of a medical curriculum: engaging with students in a large classroom setting . Advances in Physiology Education vol. 47 , ( 2 ) 237 - 242 .

( 2023 ) . Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy . The Journal of Allergy and Clinical Immunology: In Practice vol. 11 , ( 6 ) 1759 - 1770.e7 .

( 2023 ) . Cohort Profile: Post-hospitalisation COVID-19 study (PHOSP-COVID) .

( 2023 ) . Association Between T2-related Comorbidities and Effectiveness of Biologics in Adult Patients From the International Severe Asthma Registry . C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD . Conference: American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DCA4764 - A4764 .

( 2023 ) . Biologic Responders and Super-responders in the International Severe Asthma Registry . C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD . Conference: American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DCA4753 - A4753 .

( 2023 ) . Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial . The Lancet vol. 401 , ( 10387 ) 1499 - 1507 .

( 2023 ) . Mepolizumab Reduces Clinically Significant Exacerbations in Patients With Severe Asthma Prior to and During the COVID-19 Pandemic: Results From the Real-world REALITI-A Study . D21. TRANSLATIONAL COVID-19 STUDIES . Conference: American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DCA6298 - A6298 .

( 2023 ) . Comparative effectiveness of <scp>anti‐IL5</scp> and <scp>anti‐IgE</scp> biologic classes in patients with severe asthma eligible for both . Allergy vol. 78 , ( 7 ) 1934 - 1948 .

( 2023 ) . Characteristics of patients with asthma overprescribed short-acting beta-agonist (SABA) reliever inhalers stratified by blood eosinophil count in North East London: a cross-sectional observational study . BJGP Open vol. 7 , ( 2 ) BJGPO.2023.0020 - BJGPO.2023.0020 .

( 2023 ) . International consensus statement on allergy and rhinology: Allergic rhinitis – 2023 . International Forum of Allergy &amp; Rhinology vol. 13 , ( 4 ) 293 - 859 .

( 2023 ) . Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study . eClinicalMedicine vol. 57 , Article 101896 , 101896 - 101896 .

( 2023 ) . SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination . eBioMedicine vol. 87 , Article 104402 , 104402 - 104402 .

( 2022 ) . Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19 . ERJ Open Research vol. 9 , ( 1 ) 00274 - 2022 .

( 2022 ) . Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma . 05.01 - Airway pharmacology and treatment . Conference: ERS International Congress 2022 abstracts2814 - 2814 .

( 2022 ) . Characterising the impact of sex on severe asthma (SA) in the UK Severe Asthma Registry (UKSAR) . 05.02 - Monitoring airway disease . Conference: ERS International Congress 2022 abstracts308 - 308 .

( 2022 ) . Effectiveness of initiating biologics in severe asthma patients with high steroid exposure . 05.01 - Airway pharmacology and treatment . Conference: ERS International Congress 2022 abstracts3405 - 3405 .

( 2022 ) . Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients . 05.01 - Airway pharmacology and treatment . Conference: ERS International Congress 2022 abstracts3305 - 3305 .

( 2022 ) . Rebound in asthma exacerbations following relaxation of COVID-19\n restrictions: a longitudinal population-based study (COVIDENCE UK) . Thorax

( 2022 ) . Experiences of Diagnosis, Symptoms, and Use of Reliever Inhalers in Patients With Asthma and Concurrent Inducible Laryngeal Obstruction or Breathing Pattern Disorder: Qualitative Analysis of a UK Asthma Online Community (Preprint) .

( 2022 ) . P11 Characteristics and long-term real-world outcomes of severe asthma patients treated with benralizumab in the United Kingdom; the BPAP study . Deciphering ‘The Da Vinci Code’ – Biomarkers in airways disease . Conference: British Thoracic Society Winter Meeting 2022, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 23 to 25 November 2022, Programme and AbstractsA86 - A87 .

( 2022 ) . P147 Use of a connected inhaler system in the pre-biologic assessment of patients with severe asthma . ‘The Force Awakens’ – The asthma patient experience . Conference: British Thoracic Society Winter Meeting 2022, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 23 to 25 November 2022, Programme and AbstractsA161 - A162 .

( 2022 ) . P207 The influence of obesity on the clinical outcome of benralizumab treatment in severe eosinophilic asthma a subgroup analysis from the BPAP study . ‘Into the Woods’ – Managing co-morbidities in airways disease . Conference: British Thoracic Society Winter Meeting 2022, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 23 to 25 November 2022, Programme and AbstractsA192 - A193 .

( 2022 ) . P80 Rebound in asthma exacerbations following relaxation of COVID-19 restrictions . ‘Contagion’ – The impact of COVID-19 . Conference: British Thoracic Society Winter Meeting 2022, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 23 to 25 November 2022, Programme and AbstractsA124 - A125 .

( 2022 ) . S78 Biologic therapy practices in severe asthma; outcomes from the UK severe asthma registry and survey of specialist opinion . ‘The World is Not Enough’ – The epidemiological picture in airways disease . Conference: British Thoracic Society Winter Meeting 2022, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 23 to 25 November 2022, Programme and AbstractsA49.1 - A49 .

( 2022 ) . Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis . European Respiratory Review vol. 31 , ( 166 ) 220071 - 220071 .

( 2022 ) . Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both .

( 2022 ) . Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy . Journal of Asthma and Allergy vol. Volume 15 , 1491 - 1510 .

( 2022 ) . Cohort Profile: Longitudinal population-based study of COVID-19 in UK adults (COVIDENCE UK) . International Journal of Epidemiology vol. 52 , ( 1 ) e46 - e56 .

( 2022 ) . Biologic therapy practices in severe asthma; outcomes from the <scp>UK</scp> Severe Asthma Registry and survey of specialist opinion . Clinical &amp; Experimental Allergy vol. 53 , ( 2 ) 173 - 185 .

( 2022 ) . Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT) . BMJe071230 - e071230 .

( 2022 ) . Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK) .

( 2022 ) . Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study . The Lancet Respiratory Medicine vol. 10 , ( 8 ) 761 - 775 .

( 2022 ) . Association between short-term NO exposure and asthma exacerbations in East London: A time series regression model . Urban Climate vol. 44 , Article 101173 , 101173 - 101173 .

( 2022 ) . Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis . The Lancet vol. 400 , ( 10349 ) 359 - 368 .

( 2022 ) . Benefits of specialist severe asthma management: demographic and geographic disparities . European Respiratory Journal vol. 60 , ( 6 ) 2200660 - 2200660 .

( 2022 ) . Real-world use of the Breathing Pattern Assessment Tool in assessment of breathlessness post-COVID-19 . Clinical Medicine vol. 22 , ( 4 ) 376 - 379 .

( 2022 ) . Cohort Profile: Longitudinal population-based study of COVID-19 in UK adults (COVIDENCE UK) .

( 2022 ) . Reducing short-acting beta-agonist overprescribing in asthma: lessons from a quality-improvement prescribing project in East London . British Journal of General Practice vol. 72 , ( 722 ) e619 - e626 .

( 2022 ) . Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use . The Journal of Allergy and Clinical Immunology: In Practice vol. 10 , ( 6 ) 1534 - 1544.e4 .

( 2022 ) . Prevalence of Comorbidities in Adults with Severe Asthma: Results from the International Severe Asthma Registry (ISAR) . A34. TOPICS IN HEALTH SERVICES RESEARCH AND SELF-MANAGEMENT FOR PATIENTS WITH OBSTRUCTIVE LUNG DISEASE . Conference: American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CAA1306 - A1306 .

( 2022 ) . Reply to “Ethnicity-based differences in asthma diagnostic thresholds” . The Journal of Allergy and Clinical Immunology: In Practice vol. 10 , ( 4 ) 1124 - 1125 .

( 2022 ) . Vitamin D Supplements for Prevention of COVID-19 or other Acute Respiratory Infections: a Phase 3 Randomised Controlled Trial (CORONAVIT) .

( 2022 ) . A clinical review of long-COVID with a focus on the respiratory system . Current Opinion in Pulmonary Medicine vol. 28 , ( 3 ) 174 - 179 .

( 2022 ) . Development, deployment and evaluation of digitally enabled, remote, supported rehabilitation for people with long COVID-19 (Living With COVID-19 Recovery): protocol for a mixed-methods study . BMJ Open vol. 12 , ( 2 ) e057408 - e057408 .

( 2022 ) . Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial . The Lancet vol. 399 , ( 10325 ) 665 - 676 .

( 2022 ) . Ethnic Differences in Severe Asthma Clinical Care and Outcomes: An Analysis of United Kingdom Primary and Specialist Care . The Journal of Allergy and Clinical Immunology: In Practice vol. 10 , ( 2 ) 495 - 505.e2 .

( 2022 ) . Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial . The Lancet vol. 399 , ( 10320 ) 143 - 151 .

( 2022 ) . Current Management of Asthma . Encyclopedia of Respiratory Medicine , Elsevier

( 2021 ) . Clinical characteristics with inflammation profiling of Long-COVID and association with one-year recovery following hospitalisation in the UK: a prospective observational study .

( 2021 ) . The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease . The Lancet Respiratory Medicine vol. 9 , ( 12 ) 1467 - 1478 .

( 2021 ) . Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK) . Thorax vol. 77 , ( 9 ) 900 - 912 .

( 2021 ) . Adapting asthma clinical trials in response to the COVID-19 pandemic - the BenRex study design . Monitoring airway disease . Conference: ERS International Congress 2021 abstractsPA1108 - PA1108 .

( 2021 ) . The impact of ethnicity on disease presentation and control in severe asthma . Epidemiology . Conference: ERS International Congress 2021 abstractsOA1325 - OA1325 .

( 2021 ) . S88 Use of a connected inhaler system in the pre-biologic assessment of patients with severe asthma . Biologics for asthma . Conference: British Thoracic Society Winter Meeting 2021 Online, Wednesday 24 to Friday 26 November 2021, Programme and AbstractsA57.2 - A58 .

( 2021 ) . Defining a Severe Asthma Super-Responder: Findings from a Delphi Process . The Journal of Allergy and Clinical Immunology: In Practice vol. 9 , ( 11 ) 3997 - 4004 .

( 2021 ) . Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study . The Lancet Respiratory Medicine vol. 9 , ( 11 ) 1275 - 1287 .

( 2021 ) . Eosinophilic and Noneosinophilic Asthma . Chest vol. 160 , ( 3 ) 814 - 830 .

( 2021 ) . The Induction of Alpha-1 Antitrypsin by Vitamin D in Human T Cells Is TGF-β Dependent: A Proposed Anti-inflammatory Role in Airway Disease . Frontiers in Nutrition vol. 8 , Article 667203 ,

( 2021 ) . Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19 . Circulation Research vol. 129 , ( 4 )

( 2021 ) . Factors Associated with Frequent Exacerbations in the UK Severe Asthma Registry . The Journal of Allergy and Clinical Immunology: In Practice vol. 9 , ( 7 ) 2691 - 2701.e1 .

( 2021 ) . Post-COVID symptoms reported at asynchronous virtual review and stratified follow-up after COVID-19 pneumonia . Clinical Medicine vol. 21 , ( 4 ) e384 - e391 .

( 2021 ) . Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses . Frontiers in Immunology vol. 12 , Article 678570 ,

( 2021 ) . Clinical Effectiveness of Benralizumab Is Independent of Baseline FeNO in Severe Eosinophilic Asthma: A Retrospective Real-World Observation Study in Five UK Severe Asthma Centers . TP6. TP006 CLINICAL STUDIES OF ALLERGIC AIRWAY DISEASES, LUPUS, AND EOSINOPHILIC DISEASES . Conference: American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CAA1360 - A1360 .

( 2021 ) . Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial . The Lancet vol. 397 , ( 10289 ) 2049 - 2059 .

( 2021 ) . The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London . The International Journal of Tuberculosis and Lung Disease vol. 25 , ( 5 ) 358 - 366 .

( 2021 ) . Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial . The Lancet vol. 397 , ( 10285 ) 1637 - 1645 .

( 2021 ) . Improved asthma control during the COVID-19 pandemic: are there lessons to be learnt? . Thorax vol. 76 , ( 9 ) 852 - 853 .

( 2021 ) . Air Pollution and Asthma . Chest vol. 159 , ( 4 ) 1346 - 1355 .

( 2021 ) . Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study . American Journal of Respiratory and Critical Care Medicine vol. 203 , ( 7 ) 871 - 881 .

( 2021 ) . Potential Severe Asthma Hidden in UK Primary Care . The Journal of Allergy and Clinical Immunology: In Practice vol. 9 , ( 4 ) 1612 - 1623.e9 .

( 2021 ) . Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK) .

( 2021 ) . Physical, cognitive and mental health impacts of COVID-19 following hospitalisation – a multi-centre prospective cohort study .

( 2021 ) . Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial . The Lancet Respiratory Medicine vol. 9 , ( 3 ) 260 - 274 .

( 2021 ) . Dexamethasone in Hospitalized Patients with Covid-19 . New England Journal of Medicine vol. 384 , ( 8 ) 693 - 704 .

( 2021 ) . Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial . The Lancet vol. 397 , ( 10274 ) 605 - 612 .

( 2021 ) . L10 Rapid design and implementation of a personalised holistic post-COVID recovery and rehab App . COVID-19: impact on respiratory health . Conference: British Thoracic Society Winter Meeting, Wednesday 17 to Friday 19 February 2021, Programme and AbstractsA236.1 - A236 .

( 2021 ) . P172 Early clinical experience of a large hospital trust virtual Covid-19 follow up clinic . The clinical experiences of post-COVID-19 recovery . Conference: British Thoracic Society Winter Meeting, Wednesday 17 to Friday 19 February 2021, Programme and AbstractsA182.2 - A183 .

( 2021 ) . S25 The impact of COVID-19 on the UK severe asthma population . New insights in asthma care . Conference: British Thoracic Society Winter Meeting, Wednesday 17 to Friday 19 February 2021, Programme and AbstractsA18 - A18 .

( 2021 ) . Utility of immunology, microbiology, and helminth investigations in clinical assessment of severe asthma . Journal of Asthma vol. 59 , ( 3 ) 541 - 551 .

( 2020 ) . Deep mining of early antibody response in COVID-19 patients yields potent neutralisers and reveals high level of convergence .

( 2020 ) . Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures . Frontiers in Immunology vol. 11 , Article 605170 ,

( 2020 ) . Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era . Thorax vol. 76 , ( 3 ) 220 - 227 .

( 2020 ) . Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19 . New England Journal of Medicine vol. 383 , ( 21 ) 2030 - 2040 .

( 2020 ) . The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown? . ERJ Open Research vol. 7 , ( 1 ) 00768 - 2020 .

( 2020 ) . The effects of oral corticosteroids on lung function, type-2 biomarkers and patient-reported outcomes in stable asthma: A systematic review and meta-analysis . Respiratory Medicine vol. 173 , Article 106156 , 106156 - 106156 .

( 2020 ) . Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population . Monitoring airway disease . Conference: ERS International Congress 2020 abstracts5039 - 5039 .

( 2020 ) . International severe asthma registry (ISAR): protocol for a global registry . BMC Medical Research Methodology vol. 20 , ( 1 ) Article 212 ,

( 2020 ) . Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease . American Journal of Respiratory and Critical Care Medicine vol. 202 , ( 3 ) 371 - 382 .

( 2020 ) . Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signatures .

( 2020 ) . A Global Survey of Blood Eosinophil Distribution in Severe Asthma Patients: Data from the International Severe Asthma Registry (ISAR) . C21. ADVANCES IN ADULT AND PEDIATRIC ASTHMA PHENOTYPING AND ENDOTYPING . Conference: American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PAA4522 - A4522 .

( 2020 ) . Air pollution and its effects on the immune system . Free Radical Biology and Medicine vol. 151 , 56 - 68 .

( 2020 ) . Characterization of Eosinophilic and Non-Eosinophilic Severe Asthma Phenotypes and Proportion of Patients with These Phenotypes in the International Severe Asthma Registry (ISAR) . C21. ADVANCES IN ADULT AND PEDIATRIC ASTHMA PHENOTYPING AND ENDOTYPING . Conference: American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PAA4525 - A4525 .

( 2020 ) . Improvement of Clinical Outcomes in Severe Eosinophilic Asthma Patients Treated with Benralizumab in Real-World Clinical Practice in England: XALOC Study Programme . B32. ASTHMA OUTCOMES . Conference: American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PAA3028 - A3028 .

( 2020 ) . Characterization of Severe Asthma Worldwide . Chest vol. 157 , ( 4 ) 790 - 804 .

( 2020 ) . Case of paradoxical adverse response to mepolizumab with mepolizumab-induced alopecia in severe eosinophilic asthma . BMJ Case Reports vol. 13 , ( 2 ) e233161 - e233161 .

( 2019 ) . Audience response systems may help build confidence and competence in diagnosing and managing asthma . Medical education, web and internet . Conference: ERS International Congress 2019 abstractsOA5346 - OA5346 .

( 2019 ) . Epidemiology of lung function in a global severe asthma population . Monitoring airway disease . Conference: ERS International Congress 2019 abstractsPA5023 - PA5023 .

( 2019 ) . Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity . Monitoring airway disease . Conference: ERS International Congress 2019 abstractsPA2682 - PA2682 .

( 2019 ) . Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR) . Epidemiology . Conference: ERS International Congress 2019 abstractsPA2788 - PA2788 .

( 2019 ) . Protocol to identify potential severe asthma in UK primary care . Monitoring airway disease . Conference: ERS International Congress 2019 abstractsPA2712 - PA2712 .

( 2019 ) . P146 Characteristics of patients in the UK severe asthma registry . Asthma epidemiology: understanding the problem . Conference: British Thoracic Society Winter Meeting 2019, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 4 to 6 December 2019, Programme and AbstractsA170.2 - A170 .

( 2019 ) . P14 Characteristics of T2-biomarker low severe asthma patients in the UK severe asthma registry . Asthma: endotypes/biomarkers . Conference: British Thoracic Society Winter Meeting 2019, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 4 to 6 December 2019, Programme and AbstractsA95.2 - A96 .

( 2019 ) . P152 Characteristics of patients in the UK severe asthma registry: variation by ethnicity . Asthma epidemiology: understanding the problem . Conference: British Thoracic Society Winter Meeting 2019, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 4 to 6 December 2019, Programme and AbstractsA173.1 - A173 .

( 2019 ) . P155 Prevalence of urinary incontinence within a difficult asthma population . Asthma epidemiology: understanding the problem . Conference: British Thoracic Society Winter Meeting 2019, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 4 to 6 December 2019, Programme and AbstractsA174.2 - A175 .

( 2019 ) . P156 Use of the breathing pattern assessment tool within the difficult asthma service . Targeted assessment of asthma . Conference: British Thoracic Society Winter Meeting 2019, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 4 to 6 December 2019, Programme and AbstractsA175.1 - A175 .

( 2019 ) . S33 Risk factors for frequent exacerbations in a real-life adult population with severe refractory asthma . Acute asthma: lessons from the frontline . Conference: British Thoracic Society Winter Meeting 2019, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 4 to 6 December 2019, Programme and AbstractsA23.1 - A23 .

( 2019 ) . Characteristics and treatment regimens across ERS SHARP severe asthma registries . European Respiratory Journal vol. 55 , ( 1 ) 1901163 - 1901163 .

( 2019 ) . Vitamin D in pregnancy and offspring immunology . Bone Abstracts

( 2019 ) . 13th Annual Fungal Update Conference . Medical Mycology vol. 57 , ( Supplement_3 ) S257 - S258 .

( 2019 ) . Cross-Country Comparison of Demographic and Clinical Characteristics of Patients Managed in Severe Asthma Services Across UK, USA, Australia, South Korea, and Italy . C44. ASTHMA EPIDEMIOLOGY . Conference: American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TXA4899 - A4899 .

( 2019 ) . Vitamin D (1,25(OH)2D3) induces α-1-antitrypsin synthesis by CD4+ T cells, which is required for 1,25(OH)2D3-driven IL-10 . The Journal of Steroid Biochemistry and Molecular Biology vol. 189 , 1 - 9 .

( 2019 ) . Increased Chronic Obstructive Pulmonary Disease Exacerbations of Likely Viral Etiology Follow Elevated Ambient Nitrogen Oxides . American Journal of Respiratory and Critical Care Medicine vol. 199 , ( 5 ) 581 - 591 .

( 2019 ) . High-Dose IL-2 Skews a Glucocorticoid-Driven IL-17+IL-10+ Memory CD4+ T Cell Response towards a Single IL-10–Producing Phenotype . The Journal of Immunology vol. 202 , ( 3 ) 684 - 693 .

( 2018 ) . The Impact of Real-World Particulate Matter Air Pollution on the Airways of Susceptible Individuals . American Journal of Respiratory and Critical Care Medicine vol. 198 , ( 11 ) 1362 - 1363 .

( 2018 ) . Patient-reported side effects of oral corticosteroids . Medical education, web and internet . Conference: ERS International Congress 2018 abstractsPA3144 - PA3144 .

( 2018 ) . Effects of vitamin D on inflammatory and oxidative stress responses of human bronchial epithelial cells exposed to particulate matter . PLOS ONE vol. 13 , ( 8 ) e0200040 - e0200040 .

( 2018 ) . Vitamin D in Asthma . Chest vol. 153 , ( 5 ) 1229 - 1239 .

( 2018 ) . Variation in lung function and alterations in cardiac structure and function—Analysis of the UK Biobank cardiovascular magnetic resonance imaging substudy . PLOS ONE vol. 13 , ( 3 ) e0194434 - e0194434 .

( 2018 ) . Targeting the exposome: does correcting vitamin D deficiency have potential to treat and prevent asthma? . Expert Review of Clinical Immunology vol. 14 , ( 4 ) 241 - 243 .

( 2018 ) . Ambient Particulate Matter and Oxides of Nitrogen Are Associated with an Increased Incidence of COPD Exacerbations with Symptoms of Infective Etiology . AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE . vol. 197 ,

( 2018 ) . Chapter 104 Vitamin D and Adaptive Immunology in Health and Disease . Vitamin D , Elsevier

( 2018 ) . Vitamin D and Adaptive Immunology in Health and Disease . Vitamin D , Elsevier

( 2018 ) . Vitamin D supplementation during pregnancy: Effect on the neonatal immune system in a randomized controlled trial . Journal of Allergy and Clinical Immunology vol. 141 , ( 1 ) 269 - 278.e1 .

( 2017 ) . Dendritic cell phenotype in severe asthma reflects clinical responsiveness to glucocorticoids . Clinical &amp; Experimental Allergy vol. 48 , ( 1 ) 13 - 22 .

( 2017 ) . Urban particulate matter stimulation of human dendritic cells enhances priming of naive <scp>CD</scp>8 T lymphocytes . Immunology vol. 153 , ( 4 ) 502 - 512 .

( 2017 ) . P20 Latent helminth disease as a cause of eosinophilia in respiratory patients . Asthma: airways and antibodies . Conference: British Thoracic Society Winter Meeting 2017, QEII Centre Broad Sanctuary Westminster London SW1P 3EE, 6 to 8 December 2017, Programme and AbstractsA92.2 - A93 .

( 2017 ) . Differences in the coronal proteome acquired by particles depositing in the lungs of asthmatic versus healthy humans . Nanomedicine: Nanotechnology, Biology and Medicine vol. 13 , ( 8 ) 2517 - 2521 .

( 2017 ) . Vitamin D Counteracts an IL-23–Dependent IL-17A⁺IFN-<i>γ</i>⁺ Response Driven by Urban Particulate Matter . American Journal of Respiratory Cell and Molecular Biology vol. 57 , ( 3 ) 355 - 366 .

( 2017 ) . An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation . Respiratory Research vol. 18 , ( 1 ) Article 93 ,

( 2017 ) . An Imbalance between Proteases and Endogenous Protease Inhibitors in Eosinophilic Airway Disease . American Journal of Respiratory and Critical Care Medicine vol. 195 , ( 6 ) 707 - 708 .

( 2016 ) . P121 Urban fine and coarse mode particulate matter differentially alter the maturation of monocyte-derived dendritic cells . Thorax vol. 71 , ( Suppl 3 ) A148.2 - A149 .

( 2016 ) . Eosinophilia and predominant Th2 immune responses are rarely evident in disseminated tuberculosis . 10.2 Tuberculosis . Conference: ERS International Congress 2016 abstractsPA2704 - PA2704 .

( 2016 ) . Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid . Nanomedicine: Nanotechnology, Biology and Medicine vol. 12 , ( 4 ) 1033 - 1043 .

( 2016 ) . Urban Particulate Matter–Activated Human Dendritic Cells Induce the Expansion of Potent Inflammatory Th1, Th2, and Th17 Effector Cells . American Journal of Respiratory Cell and Molecular Biology vol. 54 , ( 2 ) 250 - 262 .

( 2015 ) . Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol . Journal of Allergy and Clinical Immunology vol. 136 , ( 3 ) 628 - 637.e4 .

( 2015 ) . Vitamin D enhances production of soluble ST2, inhibiting the action of IL-33 . Journal of Allergy and Clinical Immunology vol. 135 , ( 3 ) 824 - 827.e3 .

( 2014 ) . Vitamin D Influences Asthmatic Pathology through Its Action on Diverse Immunological Pathways . Annals of the American Thoracic Society vol. 11 , ( Supplement 5 ) S314 - S321 .

( 2014 ) . S48 Air Pollution Particulate Matter Promotes Dc Maturation And Enhances Their Stimulation Of Cd8 Lymphocyte Responses . Thorax vol. 69 , ( Suppl 2 ) A27 - A28 .

( 2014 ) . T2 Vitamin D Enhances Bronchial Epithelial Cell Antioxidant Responses And Reduces Their Pro-inflammatory Cytokine Response To Stimulation By Urban Particulate Matter . Thorax vol. 69 , ( Suppl 2 ) A1 - A1 .

( 2014 ) . Immunoregulatory mechanisms of vitamin D relevant to respiratory health and asthma . Annals of the New York Academy of Sciences vol. 1317 , ( 1 ) 57 - 69 .

( 2014 ) . Urban Particulate Matter Suppresses Priming of T Helper Type 1 Cells by Granulocyte/Macrophage Colony–Stimulating Factor–Activated Human Dendritic Cells . American Journal of Respiratory Cell and Molecular Biology vol. 50 , ( 2 ) 281 - 291 .

( 2014 ) . Calcitriol restores glucocorticoid responsiveness in steroid resistant asthmatics through reduction of IL-17A . IMMUNOLOGY . vol. 143 , 50 - 50 .

( 2014 ) . Prognostic scoring models can be surrogates of plasma cytokine levels and predict a prolonged intensive care unit stay in cardiac surgery . Experimental and Clinical Cardiology vol. 20 , ( 7 ) 329 - 357 .

( 2013 ) . Vitamin D treatment reduces inflammatory cytokine secretion by pollution-stimulated bronchial epithelial cells . The Lancet vol. 381 , S87 - S87 .

( 2012 ) . Vitamin D and lung disease . Thorax vol. 67 , ( 11 ) 1018 - 1020 .

( 2012 ) . Outcomes and patterns of infections in patients with underlying haematological malignancies admitted to intensive care . British Journal of Anaesthesia vol. 109 , ( 2 ) 291 - 292 .

( 2012 ) . The spleen, bone marrow and blood . Sarcoidosis , CRC Press

( 2011 ) . Are weekend handovers of adequate quality for the on-call general medical team? . Clinical Medicine vol. 11 , ( 6 ) 536 - 540 .

( 2011 ) . Outcome of haematology patients admitted to intensive care in a tertiary centre: primary haematological diagnosis, recent chemotherapy and bone marrow transplantation are not associated with outcome . Critical Care vol. 15 , ( S1 ) Article P497 ,

( 2011 ) . Patterns of infection and impact on outcome in haematology patients admitted to intensive care . Critical Care vol. 15 , ( S1 ) Article P496 ,

( 2010 ) . Pulmonary puzzle Eosinophilia, meningitis and pulmonary nodules in a young woman . THORAX vol. 65 , ( 12 ) 1066 - 1085 .

( 2007 ) . Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour . The Lancet Oncology vol. 8 , ( 8 ) 744 - 746 .

( 2003 ) . The psychosocial and psychiatric side of cystic fibrosis in adolescents and adults . Journal of Cystic Fibrosis vol. 2 , ( 2 ) 61 - 68 .

. Risk Factors for Developing COVID-19: A Population-Based Longitudinal Study (COVIDENCE UK) . SSRN Electronic Journal